EUVIMEDEUVIMED entdecken
Crossref

Antivirulence Benzothiophenes Inhibit Intracellular Mycobacterium tuberculosis by Targeting the Sensor Histidine Kinase MprB

Vladislav Lobanov, Andréanne Lupien iD, Anthony Vocat, Rajkumar Singh, Alexander Lepioshkin, Natalia Monakhova, Olga Riabova, Maria G Khrenova, Stewart T Cole, Vadim Makarov iD

Journal of Medicinal Chemistry · 2026

DOI: 10.1021/acs.jmedchem.6c01530 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2026. Verfasst von Vladislav Lobanov und 9 weiteren Autor:innen. Beteiligte Einrichtung: Research Centre of Biotechnology RAS , 33-2 Leninsky Prospect, 119071Moscow, Russia. Hauptthemen laut MEDLINE: Thiophenes, Mycobacterium tuberculosis, Antitubercular Agents, Histidine Kinase. Die Arbeit nennt 35 Literaturangaben. Gefördert von: Swiss National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary tuberculosis remains one of the most prevalent and threatening infectious diseases. Classical anti-tubercular therapy targets essential enzymes of the pathogen Mycobacterium tuberculosis (Mtb), thereby suppressing bacterial growth. However, the emergence of drug-resistant strains necessitates alternative therapeutic approaches. Virulence inhibition is a promising strategy that blocks Mtb virulence factors required for survival within host cells. We previously identified a hit compound, BTP15, which protected fibroblasts and THP-1 macrophages from Mtb-induced cell death ex vivo by blocking phagosomal escape through inhibition of the mycobacterial histidine kinase MprB. Due to poor pharmacokinetics, the structure of BTP15 was optimized. New benzothiophene derivatives were screened for MprB inhibition, microsomal stability, toxicity, and ex vivo efficacy in THP-1 and MRC-5 cells. The lead compound, 7a, exhibited favorable pharmacokinetic parameters, showed no toxicity in mice at 250 mg/kg, and prevented Mtb dissemination in an acute mouse model of tuberculosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThiophenesMycobacterium tuberculosisAntitubercular AgentsHistidine KinaseBacterial ProteinsProtein Kinase InhibitorsAnimalsHumansMiceStructure-Activity RelationshipVirulenceFemale

Stichwörter der Autor:innen

ESX-1 systemanti-infective agentbenzothiophenehistidine kinase MprBmycobacterial virulencepathoblockertuberculosisvirulence inhibitor

Substanzen

ThiophenesAntitubercular AgentsbenzothiopheneHistidine KinaseBacterial ProteinsProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Research Centre of Biotechnology RAS , 33-2 Leninsky Prospect, 119071Moscow, Russia.
  • Global Health Institute, Ecole Polytechnique Fédérale de Lausanne, 1015Lausanne, Switzerland.

ORCID-Profile: Andréanne Lupien, Vadim Makarov

Förderung

  • Swiss National Science Foundation

Zitieren

APA

Lobanov, V., Lupien, A., Vocat, A., Singh, R., Lepioshkin, A., Monakhova, N., Riabova, O., Khrenova, M. G., Cole, S. T., & Makarov, V. (2026). Antivirulence Benzothiophenes Inhibit Intracellular Mycobacterium tuberculosis by Targeting the Sensor Histidine Kinase MprB. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c01530

Vancouver

Lobanov V, Lupien A, Vocat A, Singh R, Lepioshkin A, Monakhova N, et al. Antivirulence Benzothiophenes Inhibit Intracellular Mycobacterium tuberculosis by Targeting the Sensor Histidine Kinase MprB. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.6c01530

BibTeX
@article{Lobanov2026,
  author = {Lobanov, Vladislav and Lupien, Andréanne and Vocat, Anthony and Singh, Rajkumar and Lepioshkin, Alexander and Monakhova, Natalia and Riabova, Olga and Khrenova, Maria G and Cole, Stewart T and Makarov, Vadim},
  title = {Antivirulence Benzothiophenes Inhibit Intracellular Mycobacterium tuberculosis by Targeting the Sensor Histidine Kinase MprB},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  doi = {10.1021/acs.jmedchem.6c01530}
}
Kostenlos starten →